Asbestos is still with us: Repeat call for a universal ban

Archives of Environmental and Occupational Health

Volumn 65, Issue 3, 2010, Pages 121-126

  Ramazzini, Collegium ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CEMENT; CHRYSOTILE; POLIOMYELITIS VACCINE; POLYETHYLENE;

ASBESTOSIS; ENVIRONMENTAL EXPOSURE; HUMAN; INTERNATIONAL COOPERATION; LEGISLATION AND JURISPRUDENCE; MINING; OCCUPATIONAL EXPOSURE; PREVENTION AND CONTROL; SUPPLY AND DISTRIBUTION; UNITED NATIONS; ASIA; AUSTRALIA; CARCINOGENICITY; CHINA; CLINICAL TRIAL; DIGESTIVE SYSTEM CANCER; EASTERN EUROPE; ECONOMIC ASPECT; INCIDENCE; JAPAN; LARYNX CANCER; LUNG CANCER; MEDICINE; MESOTHELIOMA; MORTALITY; MULTICENTER STUDY; NETHERLANDS; NORTH AMERICA; OVARY CANCER; PRIORITY JOURNAL; REVIEW; WESTERN EUROPE;

ASBESTOS; ASBESTOSIS; ENVIRONMENTAL EXPOSURE; HUMANS; INTERNATIONAL COOPERATION; MINING; OCCUPATIONAL EXPOSURE; UNITED NATIONS;

EID: 77956240335     PISSN: 19338244     EISSN: 21544700     Source Type: Journal    
DOI: 10.1080/19338241003776104     Document Type: Article

References (63)

1. Collegium Ramazzini. 1999. Call for an international ban on asbestos. J Occup Environ Med, 41:830–832.
2. Straif, K, Benbrahim-Tallaa, L, Baan, R, Grosse, Y, Secretan, B, El Ghissassi, F, Bouvard, V, Guha, N, Freeman, C, Galichet, L, Cogliano, V, and WHO International Agency for Research on Cancer Monograph Working Group. 2009. A review of human carcinogens—part C:metals, arsenic, dusts, and fibres. Lancet Oncol, 10:453–454.
3. EPA (Environmental Protection Agency). June, 1986. Airborne Asbestos Health Assessment Update, Washington, DC:EPA. EPA/6000/8–84/003E
4. IARC (International Agency for Research on Cancer). 1977. Asbestos:Monograph on the Evaluation of Carcinogenic Risk to Man, Vol. 14, Lyon, France:IARC.
5. NTP (National Toxicology Program). 1980. Report on Carcinogens, 1st ed, Washington, DC:US Department of Health and Human Services, Public Health Service.
6. Welch, L S. 2007. Asbestos exposure causes mesothelioma, but not this asbestos exposure:an amicus brief to the Michigan Supreme Court. Int J Occup Environ Health, 13:318–327.
7. Hillerdal, G. 1999. Mesothelioma:cases associated with non-occupational and low dose exposures. Occup Environ Med, 56:505–513.
8. Goldberg, M, Banaei, A, Goldberg, S, Anvert, B, Luce, D, and Gueguen, A. 2000. Past occupational exposure to asbestos among men in France. Scand J Work Environ Health, 26:52–61.
9. Driscoll, T, Nelson, D I, Steenland, K, Leigh, J, Concha-Barrientos, M, and Fingerhut, M. 2005. The global burden of disease due to occupational carcinogens. Am J Ind Med, 48:419–431.
10. Rake, C, Gilham, C, Hatch, J, Darnton, A, Hodgson, J, and Peto, J. 2009. Occupational, domestic and environmental mesothelioma risks in the British population:a case-control study. Br J Cancer, 100:1175–1183.
11. Tossavainen, A. 2004. Global use of asbestos and incidence of mesothelioma. Int J Occup Environ Health, 10:22–25.
12. Tossavainen, A. 1997. Asbestos, asbestosis and cancer:the Helsinki criteria for diagnosis and attribution. Consensus report. Scand J Work Environ Health, 23:311–316.
13. Leigh, J, and Driscoll, T. 2003. Malignant mesothelioma in Australia, 1945–2002. Int J Occup Environ Health, 9:206–217.
14. Stayner, L, Smith, R, Bailer, J, Gilbert, S, Steenland, K, Dement, J, Brown, D, and Lemen, R. 1997. Exposure-response analysis of risk of respiratory disease associated with occupational exposure to chrysotile asbestos. Occup Env Med, 54:646–652.
15. WHO (World Health Organization). 1998. Environmental Health Criteria 203:Chrysotile Asbestos, Geneva, Switzerland:WHO.
16. Pasetto, R, Comba, P, and Marconi, A. 2005. Mesothelioma associated with environmental exposures. Med Lav, 96:330–337.
17. Camus, M, Siemiatycki, J, and Meek, B. 1998. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med, 338:1565–1571.
18. Marier, M, Charney, W, Rousseau, R, Lanthier, R, and Van Raalte, J. 2007. Exploratory sampling of asbestos in residences near Thetford Mines:the public health threat in Quebec. Int J Occup Environ Health, 13:386–397.
19. Driece, H A, Siesling, S, Swuste, P H, and Burdorf, A. 2010. Assessment of cancer risks due to environmental exposure to asbestos. J Expo Sci Environ Epidemiol, 20:478–485.
20. Strickler, H D, Goedert, J J, Devesa, S S, Lahey, J, Fraumeni, J F, and Rosenberg, P S, Jr. 2003. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst, 95:38–45.
21. Tomatis, L, Cantoni, S, Carnevale, F, Merler, E, Mollo, F, Ricci, P, Silvestri, S, Vineis, P, and Terracini, B. 2007. The role of asbestos fiber dimension in the prevention of mesothelioma. Int J Occup Environ Health, 13:64–69.
22. Silverstein, M A, Welch, L S, and Lemen, R. 2009. Developments in asbestos cancer risk assessment. Am J Ind Med, 15:850–858.
23. Michaels, D. 2006. Manufactured uncertainty:protecting public health in the age of contested science and product defense. Ann N Y Acad Sci, 1076:149–162.
24. Michaels, D., 2008. Doubt Is Their Product. How Industry's Assault on Science Threatens Your Health., New York:Oxford University Press.
25. Michaels, D, and Monforton, C. 2007. How litigation shapes the scientific literature:asbestos and disease among automobile mechanics. J Law Policy, 5:1137–1169.
26. Boden, L I, and Ozonoff, D. 2008. Litigation-generated science:why should we care?. Environ Health Perspect, 116:117–122.
27. ICMJE (International Committee of Medical Journal Editors). Uniform Requirements for Manuscripts Submitted to Biomedical Journals:Writing and Editing for Biomedical Publications. Available at:http://www.icmje.org/
28. Braun, L, Greene, A, Manseau, M, Singhal, R, Kisting, S, and Jacobs, N. 2003. Scientific controversy and asbestos:Making disease invisible. Int J Occup Environ Health, 9:194–205.
29. ACGIH (American Conference of Governmental Industrial Hygienists). 2001. Asbestos:TLV Chemical Substances 7th Edition Documentation, Cincinnati OH:ACGIH. Publication no. 7DOC-040
30. ATSDR (Agency for Toxic Substances and Disease Registry). 2001. Toxicological Profile for Asbestos, Atlanta, GA:US Department of Health and Human Services.
31. ILO (International Labour Organization). 2006. ILO adopts new measures on occupational safety and health, the employment relationship, asbestos. International Labour Organization, Available at:http://www.ilo.org/public/english/bureau/inf/pr/2006/34.htm
32. ISSA (International Social Security Association). Septembre 16, 2004. Déclaration sur l’amiante, Pékin
33. NTP (National Toxicology Program). 2004. Report on Carcinogens, 11th ed, Washington, DC:US Department of Health and Human Services, Public Health Service.
34. NCI (National Cancer Institute). 2003. Factsheet—Asbestos:Questions and Answers, Bethesda, MD:National Institutes of Health.
35. OSHA (Occupational Safety and Health Administration). 1994. Occupational exposure to asbestos:final rule. Fed Register., 59:40964–41162.
36. American Thoracic Society Ad Hoc Committee on Update of 1986 Criteria for the Diagnosis of Nonmalignant Asbestos-Related Disease:Guidotti TL, Mille A, Christiani, D, Wagner, G, Balmes, J, Harber, P, Brodkin, C A, Rom, W, Hillerdal, G, Harbut, M, and Green, F HY. 2004. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med Vol. 170, 691–715.
37. WHO (World Health Organization). 2006. Elimination of Asbestos Related Diseases, Geneva, Switzerland:WHO.
38. WTO (World Trade Organization). 2000. European Communities—Measures Affecting Asbestos and Asbestos-containing Products, Geneva, Switzerland:WTO. WT/DS135/R
39. McCulloch, J. 2006. Saving the asbestos industry, 1960 to 2006. Public Health Rep., 121:609–614.
40. Renner, R. 2007. Chrysotile on ice. Environ Health Perspect, 115 (3):130
41. Gibbs, G W, and Berry, G. 2008. Mesothelioma and asbestos. Regul Toxicol Pharmacol, 52 (1 Suppl):S223–S231.
42. Chrysotile Institute. 2008. The crusade against chrysotile must end. Newsletter., 7:2 Available at:http://www.chrysotile.com/data/newsletter/Chrysotile_Dec2008_EN.pdf
43. Bang, K M, Pinheiro, G A, Wood, J M, and Syamlal, G. 2006. Malignant mesotheilioma mortality in the United States, 1999–2001. Int J Occup Environ Health, 12:2–15.
44. Landrigan, P, Nicholson, W J, Suzuki, Y, and LaDou, J. 1999. The hazards of chrysotile asbestos:a critical review. Ind Health, 37:271–280.
45. Lemen, R A. 2004. Chrysotile asbestos as a cause of mesothelioma:application of the Hill causation model. Int J Occup Environ Health, 10:233–239.
46. Lin, R T, Takahashi, K, Karjalainen, A, Wilson, D, Kameda, T, Chan, C C, Wen, C P, Furuva, S, Higashi, T, Chan, L C, and Ohtaki, M. 2007. Ecological association between asbestos-related diseases and historical asbestos consumption:an international analysis. Lancet, 369:844–849.
47. Smith, A H, and Wright, C C. 2006. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med, 30:252–266.
48. Stayner, L T, Dankovic, D A, and Lemen, R A. 1996. Occupational exposure to chrysotile asbestos and cancer risk:a review of the amphibole hypothesis. Am J Pub Health, 86:179–186.
49. Lemen, R A. 2004b. Asbestos in brakes:exposure and risk of disease [review]. Am J Iind Med, 45:229–237.
50. Frank, A L, Dodson, R F, and Williams, M G. 1998. Carcinogenic implications of the lack of tremolite in UICC reference chrysotile. Am J Ind Med, 34:314–317.
51. Li, L, Sun, T D, Zhang, X, Lai, R N, Li, S Y, Fan, X J, and Morinaga, K. 2004. Cohort studies on cancer mortality among workers exposed only to chrysotile asbestos:a meta-analysis. Biomed Environ Sci, 17:459–468.
52. Mirabelli, D, Calisti, R, Barone-Adesi, F, Fornero, E, Merletti, F, and Magnani, C. 2008. Excess of mesotheliomas alter exposure to chrystoile in Balangero, Italy. Occup Environ Med, 65:815–819.
53. Burki, T. 2010. Health experts concerned over India's asbestos industry. Lancet, 375:626–627. Available at:http://www.thelancet.com/journals/lancet/article/PIIS0140–6736(10)60251–6/fulltext
54. CBC (Canadian Broadcasting Corporation). June 10, 2009. Canada's Ugly Secret. The National, Available at:http://www.cbc.ca/thenational/
55. Castleman, B. 2002. WTO confidential:The case of asbestos. Int J Health Serv, 32:489–501.
56. USGS (U.S. Geological Survey). US Department of the Interior. 2008 Minerals Yearbook, Volume I.—Metals and Minerals, Asbestos. Available at:http://minerals.usgs.gov/minerals/pubs/commodity/asbestos/index.html#myb
57. LaDou, J. 2004. The asbestos cancer epidemic. Env Health Perspect, 112:285–290.
58. Terracini, B. 2008. Rotterdam Convention:chrysotile is still in the waiting list [in Italian]. Epidemiol Prev, 32:275–276.
59. WBG (World Bank Group). May 2009. Good Practice Note:Asbestos:Occupational and Community Health Issues Available at:http://siteresources.worldbank.org/EXTPOPS/Resources/AsbestosGuidanceNoteFinal.pdf
60. Leigh, J. 18–21 March, 2001. Asbestos-related diseases:international estimates of future liability [abstract]. 5th International Congress on Work Injuries Prevention, Rehabilitation and Compensation & 2nd Australian National Workers Compensation Symposium, Adelaide, Australia
61. Castleman, B., 2003. “Controlled use” of asbestos. Int J Occup Environ Health, 9:294–298. 2003
62. Egilman, D, Fehnel, C, and Bohme, S R. 2003. Exposing the “myth” of ABC, “anything but chrysotile”:a critique of the Canadian asbestos mining industry and McGill University chrysotile studies. Am J Ind Med, 44:540–557.
63. Egilman, D, and Roberts, M. 2004. Controlled use of asbestos. Int J Occup Environ Health, 10:99–103.